UBS Cuts BUD APAC (01876) Target Price to HK$8.75, Maintains "Buy" Rating

Stock News
10/31

UBS released a research report stating that BUD APAC (01876) reported Q3 2025 revenue and adjusted EBITDA of $1.555 billion and $438 million, respectively, down 8.8% and 8.6% year-on-year. These figures were 1-3% below the bank's expectations but broadly in line with market consensus.

The bank lowered its 2025–2027 earnings forecasts for BUD APAC by 7–9%, citing persistent weakness in the Chinese market and limited visibility for Q4, with recovery now expected to be delayed until 2026.

Despite the downward revision, UBS maintained a "Buy" rating, citing premiumization trends in the home consumption channel, attractive valuation, and strong cash reserves sufficient to support stable dividends in 2025. The target price was reduced from HK$9.07 to HK$8.75.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10